Clinical Trials Sponsored by Baxter Innovations GmbH

Total 150 results

Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Oxidized Cellulose hEmostAsis evaluatioN (OCEAN)

Intra-operative Bleeding

Czech Republic, Germany, Hungary, Poland
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Bleeding (Oozing) in Hepatic Resection

Germany
Ology Bioservices
Baxter Innovations GmbH

Completed

Japanese Pediatric H5N1 Vaccine Study

Influenza

Japan
Ology Bioservices
Baxter Innovations GmbH

Completed

H5N1 Vaccine Study in Japanese Adults

H5N1 Influenza

Japan
Tem Innovations GmbH

Unknown

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals (ROSI-EVA)

Blood Coagulation Disorders

United States, Austria, Switzerland
Baxalta now part of Shire
Baxter Innovations GmbH

Completed

Phase 1/2 Lyme Vaccine Study

Prophylaxis of Lyme Borreliosis

Germany, Austria
Baxalta now part of Shire
Baxter Innovations GmbH

Terminated

Early Prophylaxis Immunologic Challenge (EPIC) Study (EPIC)

Hemophilia A

Poland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
Baxalta now part of Shire
Baxter Innovations GmbH

Completed

BAX 855 Dose-Escalation Safety Study

Hemophilia A

Japan, Bulgaria, Germany, United Kingdom
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix (RESULTS)

Obesity

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation

Rotator Cuff Tear

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Acute Achilles Repair With or Without OrthADAPT Augmentation

Achilles Tendon Tear

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

Veritas in Non-Bridging Ventral Hernia Repair (VIBE)

Hernia

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)

Necrosis | Infection | Seroma

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers

Venous Leg Ulcers

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer

Diabetic Foot Ulcers

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Colorectal Cancer

United States
A.M.I. Agency for Medical Innovations GmbH

Recruiting

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

Fecal Incontinence

Spain, Austria, Germany
Urovant Sciences GmbH
Ion Channel Innovations

Terminated

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Overactive Bladder

United States
Urovant Sciences GmbH
Ion Channel Innovations

Completed

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (OAB)

Overactive Bladder

United States
Gesellschaft fur Medizinische Innovation - Hamatologie...
Crolll Gmbh

Completed

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation (Crescendo)

Chronic Myelogenous Leukemia (CML)

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH

Completed

Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q (MDS-LE-MON-5)

Myelodysplastic Syndromes

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH

Completed

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma (DSM XIII)

Multiple Myeloma

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH

Terminated

SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment

Colorectal Carcinoma

Germany
AO Innovation Translation Center
Synthes GmbH

Active, not recruiting

Effectiveness of Hemi- Versus Total Shoulder Arthroplasty Using Implants of the "Epoca" System (Epoca H vs T)

Osteoarthritis

Germany, Austria, Sweden
Atrium Innovations
Mucos Pharma GmbH, Oberhaching, Germany

Completed

The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults

Osteoarthritis | Wobenzym

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Terminated

High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock (HICOSS)

Systemic Inflammatory Response Syndrome | Kidney Failure, Acute

Germany, Austria
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application (ABBA)

Hemodialysis

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis (CIEPO-PILOT)

End-Stage Renal Disease (ESRD)

Italy
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Permeability Enhancement to Reduce Chronic Inflammation (PERCI)

Inflammation | End Stage Renal Disease

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Performance Comparison of Revaclear With Larger Dialyzer (Revacom HD)

Renal Failure Chronic Requiring Hemodialysis

Austria
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Withdrawn

High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery (HICOSIRS)

Systemic Inflammatory Response Syndrome | Acute Kidney Injury

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties

Renal Insufficiency

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Myoglobin Removal by High Cut-off CVVHD (HicoRhabdo)

Renal Failure | Rhabdomyolysis

Germany
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Terminated

Effect of HCO1100 on Cardiovascular Function (HicoCARD)

Cardiovascular Disease | Chronic Kidney Failure

Germany
SCRI Development Innovations, LLC
Bayer

Completed

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
SCRI Development Innovations, LLC
Bayer

Completed

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients

Multiple Myeloma

United States
SCRI Development Innovations, LLC
Bayer

Completed

Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors

Refractory Malignancy

United States
Takeda
Baxalta Innovations GmbH, now part of Shire

Completed

rVWF IN PROPHYLAXIS

Von Willebrand Disease

United States, Spain, Italy, Turkey, Germany, Russian Federation, Netherlands, France, Canada
SCRI Development Innovations, LLC
Bayer

Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

Ovarian Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Refractory Solid Tumors

United States
SCRI Development Innovations, LLC
Bayer

Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
SCRI Development Innovations, LLC
Bayer

Completed

Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Non-Hodgkins Lymphoma
Walter Ritter GmbH & Co

Completed

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

Erectile Dysfunction

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Unknown

Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III) (NEO-RIT)

Rectal Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Terminated

PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer (PURO)

Urinary Bladder Cancer

Germany
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Suspended

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Germany
GWT-TUD GmbH
Bayer

Completed

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Superficial Vein Thrombosis

Germany
Bayer
Steigerwald Arzneimittelwerk GmbH

Completed

Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes

Moderate Depressive Episodes (Major Depression)

Clinical Trials Sponsored by Baxter Innovations GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations